Starting HRT in perimenopause: which symptoms and history matter?

If hot flashes, night sweats, broken sleep or painful sex showed up in perimenopause, hormones may help those symptoms.

Which symptoms make HRT more likely to help?

Hot flashes and night sweats, often called vasomotor symptoms, are the main reason guidelines describe a favorable balance of benefits and risks for systemic hormone therapy in women younger than 60 or within 10 years of menopause onset who have no contraindications (AFP summary of Cochrane review).

Pain during sex from vaginal dryness responds best to estrogen. Estrogen helps restore vaginal cells, acidity and blood flow, which eases dryness-related pain. Progestins, the uterine-protecting hormones added when you have a uterus, can work against that vaginal benefit for some women (review of estrogen and desire).

What personal history changes the plan?

Your cycle pattern, sleep, mood, sexual symptoms, blood pressure, migraine history, clotting history, breast health and heart risk, plus family history, shape whether systemic hormones fit or whether you need specialist input first.

NHS primary care guidance advises specialist discussion before HRT when you have a clotting tendency called thrombophilia or a history of blood clots in veins, heart attack or stroke (NHS menopause guidance). If you get migraine with aura, clinicians often favor transdermal estradiol, the patch or gel form, because blood levels stay steadier and clot risk is lower, and aura itself raises stroke risk. A family history of breast cancer alone does not rule out HRT, but combined estrogen plus progestin raises breast cancer risk, so women with higher inherited risk need to weigh that carefully.

If you want help organizing that history, HOD's quiz walks through symptoms, migraine, clotting, heart and breast history to assess whether a hormone plan makes sense for you.

Why doesn't low desire alone decide HRT?

In trials, hormone therapy showed no effect to a small benefit on overall sexual function scores (meta-analysis). Estrogen alone probably slightly improves those scores, but almost all the trials studied postmenopausal women and only one studied perimenopausal women, so direct evidence for perimenopause is thin (Cochrane review summary). A score change is also not the same as feeling more desire day to day.

Older trials of estrogen with testosterone described the clearest link when low desire started in perimenopause or postmenopause after years of satisfying sex (2002 review of estrogen-androgen trials). When low desire came with ongoing life stress, physical illness or earlier sexual difficulties, hormones alone were unlikely to reverse it and sexual counseling was advised.